Boditech Med Inc (206640)

Currency in KRW
13,990
-140(-0.99%)
Closed·
206640 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
206640 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13,89014,240
52 wk Range
13,35021,050
Key Statistics
Bid/Ask
13,960.00 / 13,990.00
Prev. Close
13,990
Open
14,240
Day's Range
13,890-14,240
52 wk Range
13,350-21,050
Volume
72.01K
Average Volume (3m)
110.77K
1-Year Change
-24.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206640 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Boditech Med Inc Company Profile

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items. In addition, the company offers Ichroma TRIAS, ultra-high sensitivity respiratory disease diagnostic equipment; ALFIAS-3, a diagnostic equipment; and SyncNeb. Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon-si, South Korea.

Compare 206640 to Peers and Sector

Metrics to compare
206640
Peers
Sector
Relationship
P/E Ratio
10.9x9.9x−0.5x
PEG Ratio
2.89−0.290.00
Price/Book
1.4x1.1x2.6x
Price / LTM Sales
2.1x1.4x3.2x
Upside (Analyst Target)
64.4%38.3%41.6%
Fair Value Upside
Unlock27.1%6.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,272.37%
Dividend Yield
1.07%
Industry Median 1.02%
Annualised payout
150.00
Paid annually
5-Years Growth
+24.57%
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
333.00 / --
Revenue / Forecast
39.10B / --
EPS Revisions
Last 90 days

206640 Income Statement

People Also Watch

148,300
086280
+0.34%
30,550
007340
-1.77%
28,300
004990
-3.74%
38,100
009830
-2.31%
24,050
003490
-1.23%

FAQ

What Stock Exchange Does Boditech Med Trade On?

Boditech Med is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Boditech Med?

The stock symbol for Boditech Med is "206640."

What Is the Boditech Med Market Cap?

As of today, Boditech Med market cap is 304.85B.

What Is Boditech Med's Earnings Per Share (TTM)?

The Boditech Med EPS (TTM) is 1,272.37.

When Is the Next Boditech Med Earnings Date?

Boditech Med will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is 206640 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Boditech Med Stock Split?

Boditech Med has split 3 times.

How Many Employees Does Boditech Med Have?

Boditech Med has 515 employees.

What is the current trading status of Boditech Med (206640)?

As of 28 Jul 2025, Boditech Med (206640) is trading at a price of 13,990.00, with a previous close of 13,990.00. The stock has fluctuated within a day range of 13,890.00 to 14,240.00, while its 52-week range spans from 13,350.00 to 21,050.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.